Company profile for Aptar Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Aptar Pharma, we have been setting the standard for the drug delivery industry for decades and continue to break new ground in innovative healthcare technologies.Trusted partner of the pharmaceutical community, we provide a large range of specialized drug delivery devices, components and services, enabling the success of our clients. We simplify and accelerate our partners’ path through approval and compliance processes. ...
At Aptar Pharma, we have been setting the standard for the drug delivery industry for decades and continue to break new ground in innovative healthcare technologies.Trusted partner of the pharmaceutical community, we provide a large range of specialized drug delivery devices, components and services, enabling the success of our clients. We simplify and accelerate our partners’ path through approval and compliance processes. We harness healthcare trends to continuously offer innovative, convenient and safe products for all customers.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
265 Exchange Dr Crystal Lake, Illinois 60014
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260107669009/en/Aptar-Announces-2026-Quarterly-Conference-Call-Dates

BUSINESSWIRE
07 Jan 2026

https://www.businesswire.com/news/home/20260105274523/en/Aptar-to-Present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference-on-January-14-2026

BUSINESSWIRE
05 Jan 2026

https://www.businesswire.com/news/home/20251217190273/en/Aptars-Bidose-Nasal-System-Delivers-CARDAMYST-etripamil-the-First-and-Only-Self-Administered-FDA-Approved-Nasal-Spray-for-Paroxysmal-Supraventricular-Tachycardia-PSVT

BUSINESSWIRE
17 Dec 2025

https://www.businesswire.com/news/home/20251201905597/en/Aptar-Acquires-Sommaplast-a-Specialized-Provider-of-Oral-Dosing-Pharma-Packaging-Solutions

BUSINESSWIRE
01 Dec 2025

https://www.businesswire.com/news/home/20251111400044/en/Aptar-to-Present-at-Jefferies-Global-Healthcare-Conference-on-November-19-2025

BUSINESSWIRE
11 Nov 2025

https://www.businesswire.com/news/home/20251106648637/en/FillPoint-Health-Forms-Collaborative-Partnership-with-Noble-an-Aptar-Pharma-Company-to-Enhance-Patient-Experience-and-Drive-Treatment-Adherence

BUSINESS WIRE
06 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty